Reagene Innovations wins award for 3D bioprinting of human disease models
The award was given in recognition of their work on developing 3D bioprinted human models of COVID-19 and Type 2 Diabetes.
HYDERABAD: Reagene Innovations, a start-up based at Aspire BioNest, School of Life Sciences, University of Hyderabad, received the best research award at the Advances in Molecular Diagnostics and Precision Medicine International Conference, which was held in Chennai from September 15–17, 2022.
The award was given in recognition of their work on developing 3D bioprinted human models of COVID-19 and Type 2 Diabetes, which were used by the company to launch therapeutics in less than two years. 3D bioprinting is a cutting-edge technology that allows scientists to create human-like organs for drug discovery and development. The presentation was given by Arpitha Reddy, Sanjana Battula, and Saranya K of the Companies, with assistance from Kranti Meher.
Dr. Uday Saxena, Co-Founder and CEO of Reagene Innovations said that the use of 3D bioprinting of human like organs and disease systems can save the pharma industry time, several millions of dollars and increase likelihood of success in launching new products. Dr. Subrahmanyam Vangala, Co-Founder of Reagene Innovations, added that this is breakthrough technology which was much needed in an industry where failure rates are high. Dr. Satish Chandran, CEO of Lay Sciences, USA, the Company's business partner, said that bringing new products rapidly to the patient's using 3D technologies is the beginning of a new paradigm in the healthcare industry.
Reagene Innovations and its Science and Business partners, Lay Sciences USA, Prodigy Bio, USA, and Kyntox Bio, Bengaluru, intend to work closely together to bring several new product launches to market using similar innovative and proprietary discovery platforms.
Reagene Innovations appreciated the assistance given by ASPIRE-BioNest Management in both its commercial and research initiatives. The young talent working at the incubation centre is a significant aspect of its atmosphere, energy, and success, according to Dr. S. Rajagopal, Faculty at the University of Hyderabad and Director of ASPIRE-BioNest.